Unknown

Dataset Information

0

Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.


ABSTRACT: The metabolism of cancer cells is altered to support rapid proliferation. Pharmacological activators of a tumor cell specific pyruvate kinase isozyme (PKM2) may be an approach for altering the classic Warburg effect characteristic of aberrant metabolism in cancer cells yielding a novel antiproliferation strategy. In this manuscript, we detail the discovery of a series of substituted N,N'-diarylsulfonamides as activators of PKM2. The synthesis of numerous analogues and the evaluation of structure-activity relationships are presented as well as assessments of mechanism and selectivity. Several agents are found that have good potencies and appropriate solubility for use as chemical probes of PKM2 including 55 (AC(50) = 43 nM, maximum response = 84%; solubility = 7.3 microg/mL), 56 (AC(50) = 99 nM, maximum response = 84%; solubility = 5.7 microg/mL), and 58 (AC(50) = 38 nM, maximum response = 82%; solubility = 51.2 microg/mL). The small molecules described here represent first-in-class activators of PKM2.

SUBMITTER: Boxer MB 

PROVIDER: S-EPMC2818804 | biostudies-other | 2010 Feb

REPOSITORIES: biostudies-other

altmetric image

Publications

Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Boxer Matthew B MB   Jiang Jian-kang JK   Vander Heiden Matthew G MG   Shen Min M   Skoumbourdis Amanda P AP   Southall Noel N   Veith Henrike H   Leister William W   Austin Christopher P CP   Park Hee Won HW   Inglese James J   Cantley Lewis C LC   Auld Douglas S DS   Thomas Craig J CJ  

Journal of medicinal chemistry 20100201 3


The metabolism of cancer cells is altered to support rapid proliferation. Pharmacological activators of a tumor cell specific pyruvate kinase isozyme (PKM2) may be an approach for altering the classic Warburg effect characteristic of aberrant metabolism in cancer cells yielding a novel antiproliferation strategy. In this manuscript, we detail the discovery of a series of substituted N,N'-diarylsulfonamides as activators of PKM2. The synthesis of numerous analogues and the evaluation of structure  ...[more]

Similar Datasets

| S-EPMC2874658 | biostudies-literature
| S-EPMC3545759 | biostudies-literature
| S-EPMC5853155 | biostudies-literature
| S-EPMC3711671 | biostudies-literature
| S-EPMC4349452 | biostudies-literature
| S-EPMC3527123 | biostudies-literature
| S-EPMC8287349 | biostudies-literature
| S-EPMC4879880 | biostudies-literature
| S-EPMC3850755 | biostudies-literature
| S-EPMC4277479 | biostudies-literature